VMD
Viemed HealthcareANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
The best post-print bull read is that Q1 validated the March setup: revenue grew 28%, free cash flow improved, capital intensity guidance moved lower, and revenue guidance was narrowed upward. Continued execution in sleep, resupply, maternal health, and stable ventilation can support a rerating from a still-small-cap multiple base.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.3.
What can break
Adjusted EBITDA guidance was reaffirmed rather than raised, so margin conversion still needs proof even after the revenue guide moved higher.
Momentum
86
Value
65
Sentiment
45
Setup hits (3d)
— · Net —
AI TargetsBase $10.40 · Bull $13.10 · Bear $7.40
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net —
Target $11.00
Why
Momentum86 · Δ7d -1.0
Value65 · Δ7d +0.3
Sentiment45 · Δ7d -1.4
So what
Strength-led posture. Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
86
26% active weight
Current posture
7d trendFlat
Δ7d
-1.0
Δ21d
+3.4
Value
65
39% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.1
Sentiment
45
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.4
Δ21d
-5.3
Why this grade
Composite grade A. Momentum 86.0 / Value 64.9 / Sentiment 44.8
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$465.79M
Beta
1.27
Shares Out
38.34M
P/E (TTM)
21.9
P/S (TTM)
1.08
P/FCF (TTM)
51.26
Rev YoY
+27.5%
EPS YoY
+1.1%
Gross Margin
+57.0%
Op Margin
+8.3%
Net Debt
$2.45M
Current Ratio
1.22
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology